CPLX4

Chr 18

complexin 4

Also known as: CPX-IV, CPXIV

The encoded protein regulates SNARE-mediated synaptic vesicle fusion and is specifically required for maintaining synaptic ultrastructure and neurotransmitter release at photoreceptor ribbon synapses in the retina. Mutations cause autosomal recessive cone-rod dystrophy, a progressive retinal degeneration affecting both cone and rod photoreceptors. The gene shows low constraint against loss-of-function variants, consistent with its recessive inheritance pattern.

Summary from RefSeq, UniProt
Research Assistant →
0
Active trials
1
Pubs (1 yr)
74
P/LP submissions
0%
P/LP missense
1.71
LOEUF
Multiple*
Mechanism· predicted
Clinical SummaryCPLX4
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
71 unique Pathogenic / Likely Pathogenic· 24 VUS of 95 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.71LOEUF
pLI 0.000
Z-score 0.18
OE 0.92 (0.501.71)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint
0.06Z-score
OE missense 0.98 (0.821.18)
83 obs / 84.5 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.92 (0.501.71)
00.351.4
Missense OE0.98 (0.821.18)
00.61.4
Synonymous OE0.95
01.21.6
LoF obs/exp: 6 / 6.5Missense obs/exp: 83 / 84.5Syn Z: 0.22
DN
0.81top 10%
GOF
0.81top 10%
LOF
0.2386th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

95 submitted variants in ClinVar

Classification Summary

Pathogenic68
Likely Pathogenic3
VUS24
68
Pathogenic
3
Likely Pathogenic
24
VUS

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
68
0
68
Likely Pathogenic
0
0
3
0
3
VUS
0
16
8
0
24
Likely Benign
0
0
0
0
0
Benign
0
0
0
0
0
Total01679095

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

CPLX4 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →
Recent Gene-Specific Literature
Gene in title · MEDLINE · newest first
Europe PMC

No open access results found